Related Experiment Video
Updated: Jan 21, 2026

Use of Arabidopsis eceriferum Mutants to Explore Plant Cuticle Biosynthesis
Published on: May 31, 2008
Biosynthesis of an Anti-Addiction Agent from the Iboga Plant
Scott C Farrow1, Mohamed O Kamileen1, Lorenzo Caputi1
1Department of Natural Product Biosynthesis , Max Planck Institute of Chemical Ecology , Hans-Knöll-Straße 8 , 07745 Jena , Germany.
Abstract:
(-)-Ibogaine and (-)-voacangine are plant derived psychoactives that show promise as treatments for opioid addiction. However, these compounds are produced by hard to source plants, making these chemicals difficult for broad-scale use. Here we report the complete biosynthesis of (-)-voacangine, and de-esterified voacangine, which is converted to (-)-ibogaine by heating, enabling biocatalytic production of these compounds. Notably, (-)-ibogaine and (-)-voacangine are of the opposite enantiomeric configuration compared to the other major alkaloids found in this natural product class. Therefore, this discovery provides insight into enantioselective enzymatic formal Diels-Alder reactions.
Related Concept Videos
Biosynthesis in Bacteria
Biosynthesis of Polysaccharides
Biosynthesis of Lipids
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Biosynthesis of Nucleic Acids
Plant Cell Wall

